Cargando…
Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
Autores principales: | Nagaprashantha, Lokesh Dalasanur, Singhal, Jyotsana, Li, Hongzhi, Warden, Charles, Liu, Xueli, Horne, David, Awasthi, Sanjay, Salgia, Ravi, Singhal, Sharad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896966/ https://www.ncbi.nlm.nih.gov/pubmed/35261722 http://dx.doi.org/10.18632/oncotarget.28199 |
Ejemplares similares
-
2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
por: Nagaprashantha, Lokesh Dalasanur, et al.
Publicado: (2018) -
RLIP76 Regulates PI3K/Akt Signaling and Chemo-Radiotherapy Resistance in Pancreatic Cancer
por: Leake, Kathryn, et al.
Publicado: (2012) -
RLIP76, a Glutathione-Conjugate Transporter, Plays a Major Role in the Pathogenesis of Metabolic Syndrome
por: Singhal, Jyotsana, et al.
Publicado: (2011) -
2'-Hydroxyflavanone: A novel strategy for targeting breast cancer
por: Singhal, Jyotsana, et al.
Publicado: (2017) -
Anticancer activity of 2’-hydroxyflavanone towards lung cancer
por: Awasthi, Sanjay, et al.
Publicado: (2018)